Human gene
GATM glycine amidinotransferase
1 disease group in OMIA reaches this gene, through the animal gene that Ensembl gives as its ortholog. The page shows the chain. It does not say whether an animal is a model of a human disease.
Animal diseases
By each group's best natural-model score, highest first. How the score works.
| OMIA group | Name | Species | Animal gene | Ortholog | The chain reached | Best score |
|---|---|---|---|---|---|---|
| 3056 | Myopathy, creatine deficiency disorder, GATM-related | dog | GATM | one to one | Target evidence |
58.6
|
Target evidence
Each Open Targets association between this gene and a human disease that a disease group reached.
| Human disease | Mondo | Score | Evidence |
|---|---|---|---|
| AGAT deficiency | MONDO:0012996 | 0.85 | 684 |
| Fanconi renotubular syndrome 1 | MONDO:0024525 | 0.76 | 103 |
Drugs
Each ChEMBL drug that acts on this gene.
No ChEMBL drug acts on this gene, among the genes with target evidence.